Kat Steinke
Impact in
- Pharmacology top 0.5%
- Microbial Natural Products and Biosynthesis
- Microbiology top 5%
Papers in
-
- SARS-CoV-2 and COVID-19 Research 3
- COVID-19 Clinical Research Studies 2
- SARS-CoV-2 detection and testing 1
-
- Microbial Natural Products and Biosynthesis 3
- Co-authors
- Nadine Ziemert (3 shared papers)Tilmann Weber (2 shared papers)Sang Yup Lee (1 shared paper)Marnix H. Medema (1 shared paper)Kai Blin (1 shared paper)Mohammad M. Alanjary (1 shared paper)Omkar S. Mohite (1 shared paper)Ákos T. Kovács (1 shared paper)
In The Last Decade
Kat Steinke
10 papers receiving 2.9k citations
Kat Steinke's Hit Papers
Peers
Comparison fields: 5 of 66
- Pharmacology 1.4k
- Microbiology 34
- Ecology 431
- Biotechnology 107
- Molecular Biology 849
Countries citing papers authored by Kat Steinke
This map shows the geographic impact of Kat Steinke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kat Steinke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kat Steinke more than expected).
Fields of papers citing papers by Kat Steinke
This network shows the impact of papers produced by Kat Steinke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kat Steinke. The network helps show where Kat Steinke may publish in the future.
Co-authors
The 24 scholars most cited alongside Kat Steinke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | antiSMASH 5.0: updates to the secondary metabolite genome mining pipeline Hit paper breakdown → | 2019 | 2333 |
| 2 | 2019 | 373 | |
| 3 | 2021 | 70 | |
| 4 | 2020 | 48 | |
| 5 | 2023 | 46 | |
| 6 | 2021 | 17 | |
| 7 | 2023 | 8 | |
| 8 | 2024 | 2 | |
| 9 | 2024 | 1 | |
| 10 | 2025 | 1 | |
| 11 | 2026 | 1 | |
| 12 | 2024 | 0 |
About Kat Steinke
Kat Steinke is a scholar working on Infectious Diseases, Pharmacology, Molecular Medicine, Clinical Biochemistry and Molecular Biology, having authored 12 papers that have together received 2.9k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (3 papers), Microbial Natural Products and Biosynthesis (3 papers), Genomics and Phylogenetic Studies (3 papers), COVID-19 Clinical Research Studies (2 papers), Antibiotic Resistance in Bacteria (2 papers), Bacterial Identification and Susceptibility Testing (1 paper) and SARS-CoV-2 detection and testing (1 paper). The work is most often cited by research in Pharmacology (1.4k citations), Microbiology (34 citations), Ecology (431 citations), Biotechnology (107 citations) and Molecular Biology (849 citations). Kat Steinke has collaborated with scholars based in Denmark, Germany and Iceland. Frequent co-authors include Nadine Ziemert, Tilmann Weber, Sang Yup Lee, Marnix H. Medema, Kai Blin, Mohammad M. Alanjary, Omkar S. Mohite, Ákos T. Kovács, Shaun M. K. McKinnie and Leonard Kaysser. Their work appears in journals such as mSystems, Eurosurveillance, Nucleic Acids Research, Clinical Microbiology and Infection and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.